Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0002007919-25-000023
Filing Date
2025-03-17
Accepted
2025-03-17 16:20:21
Documents
2
Effectiveness Date
2025-03-17

Document Format Files

Seq Description Document Type Size
1 POS EX post-effectiveamendmentno1.htm POS EX 39355
2 EX-23.1 exhibit231bdoconsent.htm EX-23.1 2196
  Complete submission text file 0002007919-25-000023.txt   42723
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-280127 | Film No.: 25744762
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)